The "Tourette Syndrome Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis" has been added to ResearchAndMarkets.com's offering.

Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...

In May, Medtronic outlined plans to spin out its diabetes unit to create a standalone company called MiniMed. On an earnings call in November, Medtronic CFO Thierry Pieton said the planned separation ...

The Percept RC deep brain stimulation system [Image courtesy of Medtronic] Medtronic (NYSE: MDT) + announced that the FDA approved expanded labeling for its deep brain stimulation (DBS) offering. The ...

In 2003, Medtronic first received a humanitarian green light from the FDA to offer its deep brain stimulation implants to treat the symptoms of dystonia—the painful movement disorder that can cause ...

Medtronic said Wednesday it obtained U.S. clearance for its Hugo system in urologic procedures, positioning the medtech giant to challenge Intuitive Surgical in the world’s largest robotic surgery ...

Hugo is heading to the U.S., with Medtronic finally securing a stateside clearance for its robotic surgery platform. The FDA granted an initial green light to the soft-tissue system for urologic ...

The Hugo robotic-assisted surgery system now has FDA clearance for urologic procedures. [Image courtesy of Medtronic] Medtronic (NYSE: MDT) + announced today that the FDA cleared its Hugo ...

The MiniMed 780G and Instinct sensor made by Abbott. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) today announced the full U.S. launch for its Instinct sensor, made by Abbott, paired with the ...